These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 75263)

  • 21. Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection.
    Grove RB; Reba RC; Eckelman WC; Goodyear M
    J Nucl Med; 1974 Jun; 15(6):386-90. PubMed ID: 4133503
    [No Abstract]   [Full Text] [Related]  

  • 22. [Contribution to the scintigraphic diagnosis of malignant endothoracic tumors by 57Co labeled Bleomycin (author's transl)].
    Lucot H; Blasco A; Bollinelli R; Boneu A; Bru A; Combes PF; Vigoni A
    J Radiol Electrol Med Nucl; 1976 Jan; 57(1):69-78. PubMed ID: 56439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative efficacy of radionuclide imaging and computed tomography of the brain.
    Pendergrass HP; McKusick KA; New PF; Potsaid MS
    Radiology; 1975 Aug; 116(02):363-6. PubMed ID: 1153738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 57Co-bleomycin and 67Ga-citrate in detecting and staging lung cancer.
    Nieweg OE; Beekhuis H; Piers DA; Sluiter HJ; van der Wal AM; Woldring MG
    Thorax; 1983 Jan; 38(1):16-21. PubMed ID: 6189233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 111In-bleomycin imaging of breast tumours.
    Soimakallio S; Kiuru A
    Eur J Nucl Med; 1980 Aug; 5(4):369-71. PubMed ID: 6156836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The place of 57Co-bleomycin scanning in the evaluation of tumors.
    Kahn PC; Milunsky C; Dewanjee MK; Rudders RA
    AJR Am J Roentgenol; 1977 Aug; 129(2):267-73. PubMed ID: 70990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution and stability of [111In]bleomycin and its fractions in tumor-bearing mice.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
    Int J Nucl Med Biol; 1984; 11(2):129-39. PubMed ID: 6207129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain scintigraphy in the diagnosis of intracranial lesions. Comparative scanning with 169 ytterbium diethylenetriaminepenta-acetic acid and 203 mercury chlormerodrin.
    Jansen CR; Meyer BJ; Bieler EU; du Toit D
    S Afr Med J; 1973 Feb; 47(6):232-6. PubMed ID: 4689009
    [No Abstract]   [Full Text] [Related]  

  • 29. Brain scanning in neuro-ophthalmologic diagnosis.
    Henderson JW; Antine BE
    Trans Am Ophthalmol Soc; 1966; 64():274-90. PubMed ID: 5964925
    [No Abstract]   [Full Text] [Related]  

  • 30. Gallium and bleomycin scans in the clinical staging of testis tumor.
    Yeh SD; Whitmore WF; Grabstald H
    Clin Bull; 1978; 8(1):23-8. PubMed ID: 78777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical studies with In-111 BLEDTA, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent.
    Goodwin DA; Meares CF; DeRiemer LH; Diamanti CI; Goode RL; Baumert JE; Sartoris DJ; Lantieri RL; Fawcett HD
    J Nucl Med; 1981 Sep; 22(9):787-92. PubMed ID: 6168750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of cerebral lesions by Thallium 201.
    Ancri D; Basset JY; Lonchampt MF; Etavard C
    Radiology; 1978 Aug; 128(2):417-22. PubMed ID: 663252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of radio-labelled bleomycin for tumor detection.
    Rasker JJ; Beekhuis H; van de Poll MA; Versluis A; Jurjens H; Woldring MG
    Nuklearmedizin; 1978 Dec; 17(6):238-48. PubMed ID: 84374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National Cancer Institute study: evaluation of computed tomography in the diagnosis of intracranial neoplasms. I. Overall results.
    Baker HL; Houser OW; Campbell JK
    Radiology; 1980 Jul; 136(1):91-6. PubMed ID: 7384529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 57Co-bleomycin scintigraphy in staging of carcinoma of the cervix.
    Pertyński T; Durski K
    Nuklearmedizin; 1985 Feb; 24(1):48-51. PubMed ID: 2582372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring of 57Co-bleomycin delivery to brain metastases and their tumors of origin.
    Front D; Even-Sapir E; Iosilevsky G; Israel O; Frenkel A; Kolodny GM; Feinsud M
    J Neurosurg; 1987 Oct; 67(4):506-10. PubMed ID: 2443624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 57Co-labelled bleomycin scintigraphy for the detection of lung cancer: a prospective study.
    Slosman D; Polla B; Townsend D; Egeli R; Huber P; Megevand R; Donath A; Junod A
    Eur J Respir Dis; 1985 Nov; 67(5):319-25. PubMed ID: 2417879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioisotope scanning of the nervous system. Reasons for scanning.
    Claveria LE; Du Boulay G; Zingesser L
    Proc R Soc Med; 1973 Aug; 66(8):823-7. PubMed ID: 4733982
    [No Abstract]   [Full Text] [Related]  

  • 39. Cobalt-57-bleomycin scanning of hila and mediastinum in patients with bronchial carcinoma: a prospective study.
    Rasker JJ; Beekhuis H; van de Wal AM; Homan van der Heide JN; Woldring MG
    Thorax; 1976 Dec; 31(6):641-9. PubMed ID: 65019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 57-cobalt-bleomycin as a tumor scanning agent in primary hepatocellular cancer.
    Kew M; Allen J; Levin J
    Eur J Nucl Med; 1976 Dec; 1(4):247-50. PubMed ID: 72667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.